Nuo Therapeutics, Inc. (AURX)
OTCMKTS
· Delayed Price · Currency is USD
1.400
-0.050 (-3.45%)
Jul 11, 2025, 4:00 PM EDT
Nuo Therapeutics Revenue
Nuo Therapeutics had revenue of $484.38K in the quarter ending March 31, 2025, with 106.49% growth. This brings the company's revenue in the last twelve months to $1.61M, up 106.52% year-over-year. In the year 2024, Nuo Therapeutics had annual revenue of $1.37M with 124.34% growth.
Revenue (ttm)
1.61M
Revenue Growth
+106.52%
P/S Ratio
40.59
Revenue / Employee
179.44K
Employees
9
Market Cap
65.56M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
Glass House Brands | 215.62M |
American Oncology Network | 1.76B |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.70M |
Nuo Therapeutics News
- 2 months ago - Nuo Therapeutics Announces Exclusive Private Label Distribution Agreement with Smith+Nephew - GlobeNewsWire
- 3 months ago - Nuo Therapeutics and PAM Health Partner to Advance Access to Regenerative Wound Healing Therapies - GlobeNewsWire
- 2 years ago - Nuo Therapeutics Selected to Exhibit Aurix® System at Vizient Innovative Technology Exchange - GlobeNewsWire
- 2 years ago - Nuo Therapeutics' Aurix® System Added To Wound Care Formulary Of Wound Care Advantage - GlobeNewsWire
- 3 years ago - Nuo Therapeutics Provides Corporate and Business Update - GlobeNewsWire